comparemela.com
  1. Home
  2. Live Updates
  3. Presentation Selected - Breaking News

Presentation Selected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Altimmune Announces Oral Presentation of Pemvidutide Clinical Data in Treatment of NAFLD at Upcoming EASL International Liver Congress™ 2023 - Altimmune (NASDAQ:ALT)

Presentation Selected for Best of EASL Summary Slides Altimmune to Host a NASH KOL and Investor Reception on June 22, 2023 GAITHERSBURG, Md., June 15, 2023 (GLOBE NEWSWIRE) Altimmune, Inc. (NASDAQ:ALT), a

Richard eisenstadtStephena harrisonPinnacle clinical researchOxford universityInternational liver congressAltimmune incPresentation selectedInvestor receptionMedical directorAdjunct professorLiver congressMedia contacts

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.